Xiang Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiang Song has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bernard Mark Evers
University of Kentucky
24 shared publications - Bo Dong
Department of Pharmacology & Nutritional Sciences, University of Kentucky School of Medicine, Lexington, Kentucky
24 shared publications - Jianlin Wang
Department of Toxicology and Cancer Biology, University of Kentucky
24 shared publications - Jiong Deng
Medical Research Center, Affiliated Hospital of Binzhou Medical University, Binzhou, China
24 shared publications - Tao Dai
Department of Pharmacology & Nutritional Sciences, University of Kentucky School of Medicine, Lexington, Kentucky
24 shared publications - Xinzhao Wang
Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, People’s Republic of China
24 shared publications
Latest Publications
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Table S3 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
Supplemental Table S3. Tumor samples used for analysis
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
Supplemental Table S3. Tumor samples used for analysis
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Table S1 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
The used antibodies including company, catalog number and dilution.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
The used antibodies including company, catalog number and dilution.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
FBXO24 regulates LSD1 at protein levels.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
FBXO24 regulates LSD1 at protein levels.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Table S2 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
The sequence of primers for RT-qPCR and ChIP-qPCR.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
The sequence of primers for RT-qPCR and ChIP-qPCR.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 4 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
The expression of FBXO24 is inversely associated with the expression of LSD1.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 4 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
The expression of FBXO24 is inversely associated with the expression of LSD1.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
FBXO24 blocks tumor migration and invasion.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
FBXO24 blocks tumor migration and invasion.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Table S4 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
Supplemental table 4. Tumor samples with Lymph node metastases of breast cancer.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
Supplemental table 4. Tumor samples with Lymph node metastases of breast cancer.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
FBXO24 blocks tumor migration and invasion.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
FBXO24 blocks tumor migration and invasion.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Table S2 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
The sequence of primers for RT-qPCR and ChIP-qPCR.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from FBXO24 suppresses breast cancer tumorigenesis by targeting LSD1 for Ubiquitination
The sequence of primers for RT-qPCR and ChIP-qPCR.